Rights and permissions
About this article
Cite this article
Carboplatin affords superior QOL versus cisplatin in NSCLC. Inpharma Wkly. 1425, 5 (2004). https://doi.org/10.2165/00128413-200414250-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414250-00011